Harvard Bioscience Inc HBIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.35
- Day Range
- $3.20–3.43
- 52-Week Range
- $2.70–5.56
- Bid/Ask
- $3.05 / $3.50
- Market Cap
- $143.32 Mil
- Volume/Avg
- 124,130 / 155,646
Key Statistics
- Price/Earnings (Normalized)
- 29.79
- Price/Sales
- 1.32
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 416
Comparables
Valuation
|
Metric
|
HBIO
|
TECH
|
AZTA
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.79 | 43.80 | 128.13 |
Price/Book Value | 2.08 | 6.30 | 1.48 |
Price/Sales | 1.32 | 11.25 | 5.44 |
Price/Cash Flow | 23.45 | 40.89 | 67.14 |
Price/Earnings
HBIO
TECH
AZTA
Financial Strength
|
Metric
|
HBIO
|
TECH
|
AZTA
|
|---|---|---|---|
Quick Ratio | 0.76 | 2.49 | 4.81 |
Current Ratio | 1.88 | 4.08 | 5.86 |
Interest Coverage | −1.45 | 14.52 | — |
Quick Ratio
HBIO
TECH
AZTA
Profitability
|
Metric
|
HBIO
|
TECH
|
AZTA
|
|---|---|---|---|
Return on Assets (Normalized) | 3.33% | 10.95% | −0.57% |
Return on Equity (Normalized) | 6.35% | 14.98% | −0.65% |
Return on Invested Capital (Normalized) | 6.15% | 12.39% | −2.14% |
Return on Assets
HBIO
TECH
AZTA
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Pzkkmsgv | Ybt | $156.8 Bil | |||
| Becton Dickinson & Co
BDX
| Zkfrxlcdd | Gfnzxb | $68.6 Bil | |||
| Alcon Inc
ALC
| Pmrxzrpx | Lltnhs | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Dwzzmqlxpp | Prp | $29.1 Bil | |||
| ResMed Inc
RMD
| Lbrjsjbxg | Wxcgsj | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Zsqhqzmrhq | Wmvmk | $20.7 Bil | |||
| The Cooper Companies Inc
COO
| Tycykpqsx | Dghklg | $18.6 Bil | |||
| Hologic Inc
HOLX
| Zmjssmqtd | Gvlzps | $18.4 Bil | |||
| Baxter International Inc
BAX
| Cdczswl | Vdyryd | $18.1 Bil | |||
| Teleflex Inc
TFX
| Hrwft | Hryx | $10.4 Bil |